Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06829914 · ClinicalTrials.gov registry record · NA
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
A NA study of Common Femoral Artery Stenosis and Calcification; Heart, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06829914: Recruiting NA study of Common Femoral Artery Stenosis and Calcification; Heart, sponsored by Baylor Research Institute.
NCT06829914 is a NA study of Common Femoral Artery Stenosis and Calcification; Heart that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06829914, a NA study of Common Femoral Artery Stenosis and Calcification; Heart, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterectomy (CFE) as the primary treatment for symptomatic CFA stenosis.
Conditions Studied
Interventions
- DEVICE Shockwave Catheter
- PROCEDURE CFA Endarterectomy
Study Locations (1)
Texas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT06829914 shows while recruiting
NCT06829914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Common Femoral Artery Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Shockwave Catheter is the first listed.
NCT06829914 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06829914 about?
NCT06829914 is a clinical study titled "Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes". The investigators hypothesize that Shockwave with DCB is non-inferior to surgical endarterectomy for common femoral artery (CFA) stenosis with regard to primary efficacy and safety endpoints. The study will challenge the current guideline that recommends common femoral endarterectomy (CFE) as the pr...
What is the current status of trial NCT06829914?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-07. Estimated completion is 2026-03-30.
What conditions does trial NCT06829914 study?
This clinical trial studies the following conditions: Common Femoral Artery Stenosis, Calcification; Heart.
What interventions are being tested in trial NCT06829914?
The interventions under investigation include: Shockwave Catheter (DEVICE), CFA Endarterectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06829914?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06829914 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06829914's enrollment target sits among peer trials
60 1165th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI